Nicotinell 21mg NICOTINE PATCHES 7 24H is a drug to treat tobacco dependence. The 14mg patches / 24 Nicotinell relieve symptoms of nicotine withdrawal, are used in early treatment of moderate smokers or heavy smokers intermediate phase.
Available expedié in 1-2 business days
Warning: Last items in stock!
Availability date:Preview the Shipping Fees - Free Shipping from 99€*
Nicotinell 21mg NICOTINE PATCHES 7 24H
For warnings, precautions for use and against-indications, please refer to the user manual.
Description Nicotinell 21mg NICOTINE PATCHES 7 24H
Patch Nicotinell 21mg 24 laboratories Novartis is a medicine that contains nicotine, only for adults from 15 years and indicated for the treatment of tobacco dependence in order to relieve the symptoms of nicotine withdrawal in patients wishing to stop tobacco use.
After application of the patch, the nicotine is gradually released and pass into the blood stream via the skin.
No contact with other harmful substances contained in tobacco smoke (carbon monoxide, tar, stimulants gas ...).
Nicotine decreases withdrawal symptoms (urgent desire for a cigarette, irritability, moodiness, anxiety, feelings of fear, hunger, weight gain, difficulty concentrating, sleep disturbances ...).
Very discreet, Patch Nicotinell 21mg / 24 is designed in the early treatment of moderate smokers (including cigarette consumption does not exceed 20 cigarettes per day) or intermediate processing heavy smokers (including cigarette smoking over 20 cigarettes per day). It continually releases (over 24 hours) of nicotine and reduces the urgent desire of the first cigarette in the morning. It helps to stop smoking, reduces the unpleasant effects of deprivation and the craving.
Application advice and advice on Nicotinell 21mg NICOTINE PATCHES 7 24H
Nicotinell Patch 21mg 24 sticks once a day and 24 hours remain on the skin:
Change the location each day to avoid skin irritation.
Remove the protective film.
Apply the patch to clean skin, smooth, dry, healthy (no traces of lotion, ointment or alcohol), preferably on the chest or on the upper arm.
Hold the patch by pressing with the palm of the hand for about 10 seconds.
During handling, avoid contact with eyes, nose and wash your hands after application.
Heavy smokers (including cigarette smoking over 20 cigarettes per day):
Patch Nicotinell 21mg / 24 hours over a period of about 4 weeks, then Nicotinell Patch 21mg / 24 hours over a period of 4 weeks and then additional Nicotinell Patch 7mg / 24h for a period of about four weeks.
Smokers with an average consumption (including cigarette consumption does not exceed 20 cigarettes per day.)
Patch Nicotinell 21mg / 24 for about 8 weeks, then Nicotinell Patch 7mg / 24 for about four weeks.
The dosage of the transdermal system should be tailored to the individual response: increase dose if smoking abstinence is not complete or if withdrawal symptoms are observed, decrease in cases of suspected overdose.
The treatment period is about 3 months, but may vary depending on the individual response. It is recommended not to use this medication beyond 6 months.
Teens should use Nicotinell Patch in case of strong tobacco addiction and after consulting a doctor or pharmacist.
Composition Nicotinell 21mg NICOTINE PATCHES 7 24H
Patch 1 Nicotinell contains 35 mg of nicotine - The mean release of active ingredient on the skin is 21 mg / 24 h.
A transdermal device (20 cm²): S (-) 35 mg nicotine. Excipients: alkaline copolymer (Eudragit E 100), qs 1 transdermal patch. Outer shell: polyester film. Matrix layer: DuroTak 280-2516, Miglyol 812, Eudragit E 100. nonwoven Support: paper. Adhesive layer: DuroTak 280-2516, miglyol 812. removable protective sheet: Polyester Film aluminized silicone.
Use caution with Nicotinell 21mg NICOTINE PATCHES 7 24H
This medication is indicated, against the following situations: Non-smoker or occasional smoker; Hypersensitivity to any component; Skin condition that may interfere with the use of a patch.
Introducing Nicotinell 21mg NICOTINE PATCHES 7 24H
Box of 7 Patches Nicotinell 21mg 24.
Our expert advice on pharmacy
Warnings and other precautions for use:
To ensure the best chance of success, the use of this drug should be accompanied by a complete cessation of tobacco use.
Due to the pharmacological effects of nicotine, some conditions require medical advice and medical monitoring: hepatic and / or renal failure severe; gastric or duodenal ulcer in evolution.
Nicotine is a toxic substance: Keep this medicine out of reach of children. Indeed, the therapeutic dose for adults could cause serious poisoning or death in children.
It is recommended to fold the patch on himself before throwing.
If severe or persistent skin reaction, it is recommended to stop the treatment and use another pharmaceutical form (see Adverse Reactions).
Experimental studies in several species have shown no teratogenic or foetotoxic effect of nicotine administered with continuous flow, and that at maternally toxic doses. Under the same conditions of administration, fetal growth retardation is observed at even higher doses in one case, the mice but not in rats or rabbits. Clinically comments yet limited number show no deleterious impact maternal or fetal nicotine used in the indication of smoking cessation.
Smoking during pregnancy can cause a delay of intrauterine growth, fetal death in utero of a premature birth, small for gestational age, which seem to correlate with the importance of impregnation smoking and period of pregnancy, because these effects are observed when the tobacco impregnation continues for the third quarter.
Nicotine given by substitution treatment is not without deleterious effects on the fetus, as evidenced by the observed hemodynamic consequences. We do, however, no epidemiological study indicating the real impact of nicotine provided by alternative treatments on the fetus or newborn.
In pregnant women, it should always recommend a complete stop smoking without replacement therapy nicotine.
In case of failure at a heavily dependent patient, cessation of the drug is possible. Indeed, the risk to the fetus in case of continued smoking during pregnancy is probably higher than expected in a nicotine replacement therapy, as is superimposed with tobacco exposure to polycyclic hydrocarbons and the carbon monoxide, and since the exposure provided by nicotine replacement therapy is not less than or greater than that associated with tobacco consumption.
The aim is to achieve complete cessation or substitution treatment before the third trimester. Smoking cessation, with or without substitution treatment should not be considered in isolation, but within the framework of a comprehensive care, taking into account the psycho-social context and other addictions possibly associated. It may be desirable to use a consulting firm specializing in smoking cessation.
In case of partial or complete failure of weaning, continued treatment with a nicotine replacement after the 6th month of pregnancy can not be considered on a case by case basis. One should keep in mind the specific effects of nicotine that may sound on the fetus, especially when near term.
Given the constancy of concentrations of nicotine with this form of substitution, breastfeeding is not recommended during treatment with this medicine.
Interaction with other medicinal products and other forms of interaction:
Tobacco may, by enzyme induction process due to aromatic hydrocarbons, decrease blood levels of certain drugs such as caffeine, theophylline, tricyclic antidepressants, flecainide, pentazocine.
The judgment, let alone brutal, tobacco, especially on the occasion of taking this medication may lead to increased concentrations of these active ingredients related to the reversibility of the effect of enzyme induction.
For drugs with a narrow therapeutic range, such as theophylline, smoking cessation should be accompanied, in addition to dose adjustment, close monitoring, clinical or biological information with the patient risk of overdose.
Its specific, cardiovascular, neurological and endocrine pharmacological properties of nicotine can, like tobacco: cause increased levels of cortisol and catecholamines; require a dose adjustment of nifedipine, beta-blockers, insulin; reduce the effect of diuretics; slowing the rate of healing of gastric ulcers by H2 antihistamines; increase the incidence of adverse effects of estrogen-progestogen.
Transdermal nicotine can cause side effects similar to nicotine administered by other modes.
Systemic side effects: palpitations. Dizziness, headache. Nausea, vomiting. Insomnia disorder fantasy.
Local side effects: erythema and itching at the application site, rarely edema, burning sensation.
These effects are largely moderate majority and resolve spontaneously soon after removal of the system.
If severe or persistent skin reaction, it is recommended to stop the treatment and use another form of nicotine replacement therapy.
Symptoms such as dizziness some, headache and insomnia may be related to smoking cessation.
An increase in the occurrence of mouth sores may occur after smoking cessation. The causal relationship is not clear.
Nicotine overdose can occur if the patient had been previously treated with very low nicotine intake or uses concomitantly with other treatments for smoking cessation nicotine.
Overdose symptoms are those of acute nicotine poisoning include nausea, salivation, abdominal pain, diarrhea, sweating, headache, dizziness, loss of hearing and general weakness. At high doses may appear hypotension, weak and irregular pulse, breathing difficulties, prostration, circulatory collapse and convulsions.
Doses of nicotine tolerated by subjects smoking during treatment can cause acute poisoning can be fatal in young children.
What to do in case of overdose:
The administration of nicotine should be discontinued immediately and symptomatic treatment should be initiated.
Assisted ventilation and oxygen will be taken if necessary.
Warnings on drugs
Please note, the drug is not a product like any other. Read the package leaflet before ordering. Do not leave medicines out of reach of children. If symptoms persist, seek the advice of your doctor or pharmacist. Beware of incompatibilities on your products in.
Tell your pharmacist online treatments underway to identify possible incompatibilities. The checkout form contains a field of customized message provided for that purpose.
Click here to find record of this drug on the website of the National Security Agency of Medicines and Health Products.
Pharmacovigilance : Report or a related side effect (s) (s) (s) the use of a drug
Save time by using the quick order form. With a few clicks , you can easily order your favorite references.
Be fan of our Facebook page and get 5 % discount!
If you are not logged in to Facebook, please first log in and then refresh this page before clicking the Like button. Otherwise, you will not get your voucher.